ACCURAY INC

For the period ended Jun 30, 2026. Filed Aug 27, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2026 · Filed Aug 27, 2026

ARAY$3.82Day change unavailableStored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets

(in thousands, except share and per share amounts)

	June 30, 2026	June 30, 2025
ASSETS
Current assets:
Cash and cash equivalents	$40,623	$57,416
Restricted cash	611	574
Accounts receivable, net of allowance for credit losses of $884 and $369 as of June 30, 2026 and June 30, 2025, respectively (a)	67,409	83,192
Inventories	147,075	141,020
Prepaid expenses and other current assets (b)	31,783	33,501
Deferred cost of revenue	276	1,762
Total current assets	287,777	317,465
Noncurrent assets:
Property and equipment, net	27,316	28,658
Investment in joint venture	5,024	4,612
Operating lease right-of-use assets, net	27,512	33,115
Goodwill	57,911	57,802
Restricted cash	7,533	4,144
Other assets	30,603	24,443
Total assets	$443,676	$470,239
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$40,554	$34,033
Accrued compensation	15,666	14,573
Operating lease liabilities	8,236	7,375
Other accrued liabilities	32,235	29,361
Customer advances	10,401	12,197
Deferred revenue, current	82,813	82,306
Short-term debt, net	1,500	12,734
Total current liabilities	191,405	192,579
Noncurrent liabilities:
Operating lease liabilities	27,768	32,482
Long-term other liabilities	5,477	5,160
Warrant liability	2,427	8,497
Deferred revenue, non-current	28,530	26,566
Long-term debt, net	146,370	123,786
Total liabilities	401,977	389,070
Commitments and contingencies (Note 8)
Stockholders’ equity:
Common stock, $0.001 par value; authorized: 200,000,000 shares as of June 30, 2026, and June 30, 2025, respectively; 122,541,809 shares issued and 119,433,440 shares outstanding as of June 30, 2026, and 115,752,221 shares issued and 112,643,852 shares outstanding as of June 30, 2025.	119	113
Additional paid-in-capital	613,559	602,165
Accumulated other comprehensive loss	(3,513)	(1,837)
Accumulated deficit	(568,466)	(519,272)
Total stockholders’ equity	41,699	81,169
Total liabilities and stockholders’ equity	$443,676	$470,239

(a)	Included accounts receivable from the joint venture, an equity method investment, of $9,900 and $28,452 at June 30, 2026, and June 30, 2025, respectively. See Note 11.

(b)	Included other receivable from the joint venture, an equity method investment, of $270 and $377 at June 30, 2026, and June 30, 2025, respectively.

The accompanying notes are an integral part of these consolidated financial statements

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.